Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
IN CONTROL--Hypertension Reduction in Inner City Seattle Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on IN CONTROL--Hypertension Reduction in Inner City Seattle conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. IN CONTROL--Hypertension Reduction in Inner City Seattle Clinical research trials and IN CONTROL--Hypertension Reduction in Inner City Seattle healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including IN CONTROL--Hypertension Reduction in Inner City Seattle. IN CONTROL--Hypertension Reduction in Inner City Seattle Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a IN CONTROL--Hypertension Reduction in Inner City Seattle clinical trial. Test subjects typically receive the most effective healthcare possible for their IN CONTROL--Hypertension Reduction in Inner City Seattle condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "I" Clinical Trials Conditions > IN CONTROL--Hypertension Reduction in Inner City Seattle

IN CONTROL--Hypertension Reduction in Inner City Seattle



IN CONTROL--Hypertension Reduction in Inner City Seattle

For Condition: Heart Diseases,Cardiovascular Diseases,Hypertension
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To implement and evaluate with a randomized, controlled trial interventions to improve control of hypertension among inner city low- income and minority residents of Seattle.
Details: BACKGROUND: Low income residents of inner city Seattle especially African Americans, have significantly higher rates of cardiovascular mortality and morbidity than other Seattle residents. Hypertension is a major risk factor for these excess deaths. The prevalence of both hypertension and uncontrolled hypertension is also higher among low income and minority residents, especially young men. The study was in response to a demonstration and education initiative, "Improving Hypertensive Care for Inner City Minorities", which was reviewed and approved by the Clinical Applications and Prevention Advisory Committee in April 1992 and by the National Heart, Lung, and Blood Advisory Council in May 1992. The Request for Applications was released in October 1992. DESIGN NARRATIVE: Two interventions were studied, both of which improved upon existing activities and strengthened the relationship between community and clinic-based hypertension control activities. The first intervention improved the identification and entry into care of new and uncontrolled hypertensives in the community with an emphasis on bringing more young males (especially African American) through: (a) screening and education activities (b) a microcomputer-based client tracking system to follow persons with elevated blood pressure (c) an outreach system to improve follow-up into clinical care. The second intervention enhanced access to and compliance with hypertension care among patients using the participating clinics (both currently registered patients and new patients referred through community screening activities) through: (a) microcomputer-based patient tracking system at each clinic to identify nonadherent and other high risk patients (b) placing a hypertension patient care coordinator at each clinic who created an individualized care plan for each patient and coordinated a wide range of services, including specific strategies to enhance compliance (c) making available outreach workers to assist in efforts to keep patients in care.
Eligibility:
Study Type:
  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:
  4277; 
Study Start Date: September 1993
Record last reviewed: July 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005698

Other Heart Diseases Studies:
1. CVD Nutrition Education for Low Literacy ESL Students

2. Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)

3. Health Professionals Follow-up Study

4. Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics (BARI 2D)

5. CVD Nutrition Education

Related Studies:

Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials

IN CONTROL--Hypertension Reduction in Inner City Seattle

Modify your Search

  Other Heart Diseases Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103